Ashley Michelle Turucz, AGPCNP in Aurora, IL - General Practice

Ashley Michelle Turucz, AGPCNP is a General Practice physician based in Aurora, Illinois. Ashley Michelle Turucz is licensed to practice in Illinois (license number 2023004684) and her current practice location is 400 N Highland Ave, Aurora, Illinois. She can be reached at her office (for appointments etc.) via phone at (630) 978-2532.

NPI number for Ashley Michelle Turucz is 1679251425 and her current mailing address is 104 Riverside Dr, Montgomery, Illinois. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1679251425.

Contact Information

	Ashley Michelle Turucz, AGPCNP
	400 N Highland Ave, Aurora, IL 60506-3814
	(630) 978-2532
	Not Available

Physician's Profile

Full Name	Ashley Michelle Turucz
Gender	Female
Speciality	General Practice
Location	400 N Highland Ave, Aurora, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1679251425
Provider Enumeration Date: 07/10/2023
Last Update Date: 07/10/2023

Medical Identifiers

Medical identifiers for Ashley Michelle Turucz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1679251425	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	2023004684 (Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ashley Michelle Turucz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ashley Michelle Turucz, AGPCNP 104 Riverside Dr, Montgomery, IL 60538-1217 Ph: (331) 222-6759	Ashley Michelle Turucz, AGPCNP 400 N Highland Ave, Aurora, IL 60506-3814 Ph: (630) 978-2532

News Archive

Research: Physical abilities of male and female tennis players decline at the same rate

The physical abilities of male and female tennis stars decline at the same rate as they age, new research shows.

Spectrum Pharmaceuticals begins Phase 2 clinical program for SPI-2012

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the Company has initiated a Phase 2 clinical program for SPI-2012 (also referred to as "LAPS-GCSF"), a drug candidate for the treatment of chemotherapy-induced neutropenia that utilizes partner Hanmi Pharmaceutical Company's proprietary LAPSCOVERY™ Technology.

Beta blockers reverse potentially detrimental genetic changes linked to heart disease

Beta blockers are commonly used world-wide to treat a variety of cardiovascular conditions, such as arrhythmias and heart failure.

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

Protalex initiates dosing in multicenter PRTX-100 Phase 1b clinical study in RA

Protalex, Inc., a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, today announced the dosing of the first patient in a multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA). The study is being conducted in South Africa.

Ashley Michelle Turucz, AGPCNP - General Practice in Aurora, IL